Related Experiment Video
Updated: Jun 20, 2026
09:37
A RANKL-based Osteoclast Culture Assay of Mouse Bone Marrow to Investigate the Role of mTORC1 in Osteoclast Formation
Published on: March 15, 2018
Control of RANKL gene expression.
1Center for Osteoporosis and Metabolic Bone Diseases, University of Arkansas for Medical Sciences, and Central Arkansas Veterans Healthcare System, Little Rock, AR 72205, USA. caobrien@uams.edu
Bone
|September 1, 2009
Summary
Osteoclast formation, crucial for bone health and disease, relies on receptor activator of NFkappaB ligand (RANKL). Understanding RANKL gene control offers new therapeutic targets for bone loss conditions.
Area of Science:
- Bone biology
- Cellular and molecular medicine
- Immunology
Background:
- Osteoclasts are specialized cells essential for bone degradation, involved in calcium homeostasis, bone modeling, and remodeling.
- Increased osteoclast production is linked to pathological conditions causing bone mass loss.
- Osteoclastogenesis requires cytokines from accessory cells, with receptor activator of NFkappaB ligand (RANKL) being indispensable for osteoclast formation.
Purpose of the Study:
- To review mechanisms controlling RANKL gene expression in osteoclast-support cells.
- To explore how understanding these mechanisms can enhance insights into normal and pathological bone resorption.
- To highlight the therapeutic potential of targeting RANKL for bone loss inhibition.
Main Methods:
- Literature review focusing on cellular interactions and molecular mechanisms controlling RANKL expression.
- Analysis of studies investigating cytokine signaling in osteoclastogenesis.
- Examination of therapeutic strategies targeting the RANKL pathway.
Main Results:
- Receptor activator of NFkappaB ligand (RANKL) is a critical and essential cytokine for osteoclast differentiation and bone resorption.
- Various cell types express RANKL, supporting osteoclast formation under physiological and pathological conditions.
- The central role of RANKL in bone resorption forms the basis for novel therapies aimed at preventing bone loss.
Conclusions:
- Targeting RANKL gene expression mechanisms provides a promising avenue for understanding and treating bone loss disorders.
- Further research into cellular interactions governing RANKL expression can lead to improved therapeutic interventions for bone diseases.
- The essential role of RANKL underscores its significance in both normal bone physiology and the pathogenesis of bone-resorptive diseases.
Related Concept Videos
02:24Regulation of Expression Occurs at Multiple Steps
Gene expression can be regulated at almost every step from gene to protein. Transcription is the step that is most commonly regulated. This involves the binding of proteins to short regulatory sequences on the DNA. This association can either promote or inhibit the transcription of a gene associated with the respective sequence.
Transcription results in the generation of precursor (pre-mRNA) that consists of both exons and introns, which needs further processing before being translated to a...
Transcription results in the generation of precursor (pre-mRNA) that consists of both exons and introns, which needs further processing before being translated to a...
02:24Regulation of Expression Occurs at Multiple Steps
Gene expression can be regulated at almost every step from gene to protein. Transcription is the step that is most commonly regulated. This involves the binding of proteins to short regulatory sequences on the DNA. This association can either promote or inhibit the transcription of a gene associated with the respective sequence.
Transcription results in the generation of precursor (pre-mRNA) that consists of both exons and introns, which needs further processing before being translated to a...
Transcription results in the generation of precursor (pre-mRNA) that consists of both exons and introns, which needs further processing before being translated to a...
01:22PI3K/mTOR/AKT Signaling Pathway
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a rapamycin-insensitive companion...
01:27Constitutive and Regulated Gene Expression
Gene expression in prokaryotes is governed by constitutive and regulated systems, allowing cells to balance the production of essential proteins with adaptive responses to environmental changes.Constitutive Gene ExpressionConstitutive, or housekeeping, genes are continuously expressed as they encode proteins vital for fundamental cellular processes. These include enzymes for glycolysis, ribosomal components for protein synthesis, and proteins involved in DNA replication. Their constant...
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
01:23Regulation of Expression at Multiple Steps
The gene expression in cells is regulated at different stages: (i) transcription, (ii) RNA processing, (iii) RNA localization, and (iv) translation. Transcriptional regulation is mediated by regulatory proteins such as transcription factors, activators, or repressors—these control gene expression by initiating or inhibiting the transcription of genes. Once a precursor or pre-mRNA is produced, it undergoes post-transcriptional modification, including 5' capping, splicing, and the addition of a...